(Q33376149)

English

Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression (English)
Heather J Sutherland
Alexander N Suvorov
Jean-Luc Harousseau

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit